Ventricular function and all-cause mortality in chronic kidney disease patients with angiographic coronary artery

I-Wen Wu1, Ming-Jui Hung, Yung-Chang Chen

  • 1Department of Nephrology, Keelung Chang Gung Memorial Hospital, Taipei; and College of Medicine, Chang Gung University, Taipei - Taiwan.

Journal of Nephrology
|February 2, 2010
PubMed

Insights

Low left ventricular ejection fraction (LVEF) is linked to chronic kidney disease (CKD) and predicts mortality in CKD patients, even those without coronary artery disease (CAD). This finding highlights LVEF as a critical prognostic factor.

Area of Science:

  • Cardiology
  • Nephrology
  • Public Health

Background:

  • Coronary artery disease (CAD) and chronic kidney disease (CKD) are significant contributors to morbidity and mortality.
  • CKD patients face risks of myocardial ischemia, chamber abnormalities, and reduced left ventricular ejection fraction (LVEF) due to various factors.
  • The prognostic value of LVEF in relation to mortality in non-dialysis CKD patients with suspected myocardial ischemia is not well-established.

Purpose of the Study:

  • To investigate the association between LVEF and CKD stages.
  • To determine the relationship between LVEF and all-cause mortality in CKD patients.
  • To assess the prognostic significance of LVEF in CKD patients with and without angiographic CAD.

Main Methods:

  • Retrospective analysis of 980 CKD patients undergoing coronary angiography (1995-2004).
  • Assessment of demographic, clinical data, and ventriculographic LVEF.
  • Application of Cox proportional hazard regression models for risk estimation.

Main Results:

  • 45.4% of CKD patients had angiographic CAD; LVEF, hemoglobin, and BMI decreased with declining eGFR.
  • Low LVEF was independently associated with CKD, irrespective of age, sex, diabetes, hypertension, BMI, hemoglobin, and CAD presence.
  • Independent predictors of mortality included diabetes, BMI, hemoglobin, and LVEF. Low LVEF was the sole independent predictor in CKD patients with angiographic CAD.

Conclusions:

  • Reduced LVEF is independently associated with CKD.
  • Low LVEF serves as an independent predictor of mortality in CKD patients, regardless of angiographic CAD status.
Abstract

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...